NCT04704011 is a NA clinical trial of 2-1-1 United Way Healthy Missouri Hotline in Colposcopy, sponsored by Washington University School of Medicine.

Who is sponsoring NCT04704011?

NCT04704011 is sponsored by Washington University School of Medicine.

What drugs are being tested in NCT04704011?

Interventions in NCT04704011: 2-1-1 United Way Healthy Missouri Hotline, National Comprehensive Cancer Network (NCCN) Distress Thermometer, Basic needs survey, 2-1-1 survey, Usual Care Reminder Call.

What condition does NCT04704011 study?

NCT04704011 studies Colposcopy.

Is NCT04704011 still recruiting?

NCT04704011 is currently withdrawn. Last updated 29 June 2022.

Last reviewed 2022-06-29 · How we verify

NCT04704011

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating the Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rates: The BASICS Trial

Withdrawn NA Last updated 29 June 2022

What this trial tests

NA trial testing 2-1-1 United Way Healthy Missouri Hotline in Colposcopy. Withdrawn.

Timeline

31 May 2022

Primary endpoint
31 May 2023

31 May 2023

Quick facts

Lead sponsor	Washington University School of Medicine
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Start date	31 May 2022
Primary completion	31 May 2023
Estimated completion	31 May 2023

Drugs / interventions tested

2-1-1 United Way Healthy Missouri Hotline
National Comprehensive Cancer Network (NCCN) Distress Thermometer
Basic needs survey
2-1-1 survey
Usual Care Reminder Call

Conditions studied

Colposcopy — all drugs for Colposcopy →

Sponsor

Washington University School of Medicine

Who can join

21 and older, female only, with Colposcopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled, single-site study hopes to determine the effectiveness of a tailored phone call reminder to improve low-income patients' adherence to colposcopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Washington University School of Medicine trials

Trials by the same sponsor.

NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04704011 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
Last refreshed: 29 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04704011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing